• About Us
• Technology
• Partnering
• Diseases
• Product Pipeline
• Investors and media
• Careers
• Contact

• News and Reports
• IR and Media Contact
• Ownership

• Press releases
• Financial Reports
• Annual Reports

• 
• 
• 
• 
• 
• 
• Dansk

• Product Pipeline

  Zealand's Pipeline comprises 1 compound in ph 3, 1 in ph 2, 3 in ph 1, and 2 in pre-clinical develop...

  Read More >

• 2010

  8 Marts 2010:Press Release no. 2, 2010: Zealand Pharma Announces Augmentation of its Management...

  Read More >

2009

1 September 2009:
Press Release no. 4, 2009: Zealand Pharma advances a new generation of Type 2 Diabetes treatment 

15 May 2009:
Press Release no.3, 2009: Zealand Pharma A/S to highlight importance of partnering in diabetes care at 2009 BIO International Convention, Atlanta, USA

18 March 2009:
Press Release no.2, 2009: Zealand Pharma A/S receives Frost & Sullivan 2008 European Research & Development Award

Award Summery         Award

3 February 2009:
Press Release no. 1, 2009: Zealand Pharma A/S advances ZP1848 for the prevention and treatment of Inflammatory Bowel Disease into Phase I clinical trials